High Integrity Sample Storage Ensured By Double O-Ring Seal
Porvair Sciences has introduced new silicone cap mats for its range of 2 mL deep well storage blocks. Incorporating a novel double O-ring feature, the new silicone cap mats ensure a tight liquid proof seal every time. Such is the quality of the seal that capped storage blocks can be shaken, inverted or frozen without any loss of stored sample integrity.
Manufactured under class 10,000 clean room conditions from high grade silicone, which is resistant to most solvents, the new cap mats contain no contaminants that may leach out and affect stored sample. The new cap mats come with a specially weakened area in a shape of a cross on each of the 96 cap/well sections. For automated sample storage applications where piercing and reassessing is required the silicone cap mats allow easy, reproducible access while maintaining a high integrity seal on individual plate wells.
Silicone double O-ring cap mats are available for Porvair Sciences complete range of round and square well 2 mL storage blocks. All Porvair 96-well storage blocks are precisely made to ANSI / SLAS dimensions ensuring complete compatibility with almost all readers, washers and automated equipment.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance